|Publication number||US3002883 A|
|Publication date||Oct 3, 1961|
|Filing date||Jul 29, 1959|
|Priority date||Jul 29, 1959|
|Publication number||US 3002883 A, US 3002883A, US-A-3002883, US3002883 A, US3002883A|
|Inventors||Frederick J Butt, Clarence L Moyle|
|Original Assignee||Dow Chemical Co|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (1), Referenced by (51), Classifications (10)|
|External Links: USPTO, USPTO Assignment, Espacenet|
3,002,883 DISBWFECTANT COMPOSITIONS Frederick J. Butt, Midland, and Clarence L. Moyle, Clare,
Mich, assignors to The Dow Chemical Company, Midland, Mich, a corporation of Delaware N Drawing. Filed July 29, 1959, Ser. No. 830,184 3 Claims. (Cl. 1'67--31) This invention relates to the production of liquid concentrate compositions which are suitable for dilution with water for use. It is more specifically concerned with concentrate compositions of phenyl-substituted phenols.
At the present time there is a growing need for detergent-disinfectant or detergent-germicide compositions for commercial, industrial and general use which have a broad spectrum of antimicrobial activity and which have Wide detergent action. Because of facility in many areas of application, there is a further demand that such detergent-germicide composition be a liquid concentrate which is readily diluted for use. Germicidal phenols of the type having a phenyl substitution with or without halogen substitution have a broad spectrum of antimicrobial nited States Patent activity, very low human toxicity, and maintain their activity in hard water and in the presence of organic contaminants, and furthermore, do not have the high corrosive properties possessed by germicides having labile chlorine. Such properties have made phenyl-substituted phenols of interest as a potential component in detergentgermicide compositions. However, phenyl-substituted phenols have found limited use in detergent-germicide compositions since surface active agents having suitable detergent properties have frequently been found to inactivate the phenols thereby resulting in loss of germicidal effectiveness. Many other detergents have been found to be non-compatible with the phenols thereby failing to form stable homogeneous compositions. Thus, non-ionic type surfactant and certain of the phosphates may effectively solubilize the phenols but decrease or remove the germicidal properties of the phenols. Others such as cationic type of surfactant are non-compatible and fail to form a concentrate composition. Still others such as most anionic and certain phosphate surfactants fail to form stable concentrate compositions or the compositions formed therewith form a precipitate on dilution with water. The problem of stable, homogeneous compositions is aggravated in built detergent disinfectant compositions where addition of builders to detergent disinfectant composition causes immediate precipitation of the disinfectant. This is of great consequence in the detergent industry since the alkaline builders greatly enhance or extend the detergent powers. Thus, there is a need for a stable homogeneous detergent disinfectant composition and further one which will retain the disinfectant properties when modified by the addition of builders.
It has been discovered according to the present invention, that an aqueous stable, liquid concentrate detergentdisinfectant composition comprising a phenyl-substituted phenol which is normally sparingly soluble in water may be obtained without inactivating the phenol with respect to its germicidal properties by incorporating in the composition a water-soluble alkyl diphenyl ether sulfonate as anionic dispersing agent whereby the phenol or phenols are maintained in solution by the presence of the anionic dispersing agent.
This invention is particularly concerned with stable aqueous, liquid concentrate compositions comprising a phenyl-substituted phenol and water-soluble alkyl diphenyl ether sulfonate. These concentrate compositions Patented Oct. 3, 1961 are clear and stable liquids which further form clear and stable solutions on dilution with water while maintaining the germicidal property of the phenyl-substituted phenols. These compositions are also stable to temperature changes, thus resisting precipitation of the phenolic material when subjected to freezing. Furthermore, these concentrate compositions require no added organic solvent to maintain the phenol in solution. it has further been found that when builders are added to said compositions, the resulting built detergent-disinfectant compositions are stable and retain their disinfectant and detergent properties. Thus, a detergent-disinfectant composition having the combination of properties of being a liquid, retaining germicidal effectiveness and maintaining homogeneity on subjection to freezing, on dilution with water, and on addition of builders is provided by this invention.
By the expression phenyl-substituted phenol or phenylphenol as herein employed is meant a monophenylphenol which may also have a chlorine substitution and may be represented by the formula In this and succeeding formulas, X is hydrogen or a chloro radical. Particularly suitable are o-phenylphenol, 2- chloroi-phenylphenol, 4-chloro-2-phenylphenol, 6-chloro-2-phenylphenol or mixtures thereof. The water-soluble salts of the phenyl-substituted phenols may also be employed when the detergent-disinfectant composition is to be in the alkaline pH range. Suitable water-soluble salts include alkali metal salts such as sodium and potassium, and ammonium salts.
The terms water-soluble alkyl diphenyl ether sulfonate or water-soluble alkyl diphenyl oxide sulfonate as herein employed are sulfonated alkyl diphenyl ether products containing alkyl substituents in amounts corresponding to from 1 to 1.3 alkyl substituents each corresponding to an alkyl radical containing from 9 to 15 carbon atoms and from 1.8 to 2.3 sulfonate groups per diphenyl ether nucleus, and may be represented by the formula In this and succeeding formulae, R is alkyl containing from 9 to 15 carbon atoms and M is a water-soluble cation. The alkyl diphenyl ether sulfonates may be prepared as described in US. Patent No. 2,854,447. By watersoluble cation as herein employed is meant alkali metal, such as sodium and potassium, or ammonium. Suitable Water-soluble alkyl diphenyl ether sulfonates to be employed in the practice of the present invention include commercially available sodium salt of disulfonated dodecyldiphenyl oxide.
A built detergent-disinfectant composition as herein employed is meant a detergent-disinfectant composition comprising a phenylphenol and a sulfonated alkyl diphenyl ether as above defined to which has been added alkaline builders. By alkaline builders is meant alkaline salts which are normally employed in detergent compositions to extend the detergent action. Builders include phosphates, particularly tetrapyrophosphates such as tetrasodium or tetrapotassium pyrophosphate, tripolyphosphates such as pentasodium tripolyphosphate, soda ash, sodium metasilicate, borax and sodium bicarbonate. When builders are employed in the detergent-disinfectant compositions they are usually added in an amount equal to the weight of the alkyl diphenyl ether sulfonate employed although two to threefold excesses of the builder may be employed. A
For the preparation of these concentrate compositions, it has been found that the ratio of the alkyl diphenyl ether sulfonate to the phenol is important. Concentrate compositions may be prepared when the relative amounts are from 1 to 20 parts by weight of alkyl diphenyl ether sulfonate to 1 part by weight of the phenyl-substituted phenol. The preferred ratios depend on whether or not the detergent-disinfectant composition contains builders. When the detergent-disinfectant composition does not contain builders, the preferred ratio of alkyl diphenyl ether sulfonate to phenol is from 2.5 :1 to 20:1. When thedetergent-disinfectant composition contains builders or alkali, the preferred ratio of sulfonate to phenol is 1:1 to 4:1. These ratios are based on the Weight of the phenyl-substituted phenol calculated as the free phenol and weight of water-soluble sulfonate.
'These concentrate detergent-disinfectant compositions containing components in the ratios above set forth, may contain the germicidal phenyl-substituted phenol in a concentration of from 1 to 12 percent by weight of the total aqueous composition, although in certain compositions 21 higher concentration of the phenyl-substituted phenol may be employed. These compositions may then be diluted to produce germicidal treating compositions as clear homogeneous solutions containing as low as 0.0025 percent by weight of the phenyl-substituted phenol Without destroying the germicidal effectiveness of the phenylsubstituted phenol. The compositions may be prepared by mixing the components together.
In a preferred method for preparing the detergentdisinfectant composition, the phenyl-substituted phenol is intimately mixed with an aqueous solution of a watersoluble alkyl diphenyl ether sulfonate. The mixing is generally carried out at room temperature with stirring until a homogeneous solution is obtained. The resulting solution may then be diluted with water, if necessary, to produce the desired composition.
The salt of the phenol is employed when a composition having relatively high alkaline pH is desired. The performed salt may be employed or a solution of alkali or ammonia may be added to the solution prepared as described above.
When the composition is a built detergent disinfectant composition, builders are added to the phenylphenol alkyl diphenyl ether sulfonate composition prepared as above described and stirred until a homogeneous composition is obtained. Additional water may be added, if desired.
The above compositions may be modified as is known In the art without departing from the spirit thereof. Thus, diluents or solvents such as polyglycol ethers particularly propylene glycol monomethyl ether and alcohols such as isopropyl alcohol may be added. However, such diluents or solvents are not necessary according to the present invention. When compositions are to be prepared containing solvents, modifying agents, etc. such additaments may be added at any point in the manufacture according to the practice followed by those skilled in the art. If the additament is a solvent, it is conveniently employed by dissolving the phenylphenol in said solvent and adding the solution to the aqueous solution of alkyl diphenyl ether sulfonate. The following examples illustrate the invention but are not to be construed as limiting.
4 i v EXAMPLE 1 Concentrate compositions having the following compositions were prepared: I
Parts by weight Composition I:
Component- Sodium salt of disulfonated dodecyldiphenyl oxide 2.0 o-Phe'nylphenol 0.5 Water 97.5 Composition II: Component Sodium salt of disulfonated dodecyldiphenyl oxide; 1.5 o-Phenylphenol 0.5 Water 98.0
In separate operations, each of the compositions were dispersed in microbiological culturing media to produce varying concentrations of the compositions, the modified culturing media poured into separate Petri dishes and the dishes streaked with species of bacteria or fungi and the inoculated dishes then incubated at 30 C. for 3 days. At the end of this period, the dishes were observed for microbial growth. The results with the concentrations at which inhibition of growth was observed are set forth in Table I. 4
A concentrate composition was prepared by mixing together the following:
Grams 50 percent aqueous solution of the sodium salt of disulfonated dodecyldiphenyl oxide 60.0 2-chloro-4-phenylphenol 1.5 Water 38.5
The resulting composition was a clear solution.
Two grams of the concentrate composition prepared as above described was dispersed in 1 liter of water to produce a clear dispersion having a pH of 7.
EXAMPLE 3 A concentrate composition was prepared by mixing together the following:
Grams Disodium nonyldiphenyl oxide disulfonate 20.0 4-chloro-2-phenylphenol 1.0 Water 45.5
The resulting concentrate composition was a clear solution.
Two grams of the concentrate composition was dispersed in 1 liter of water to produce a clear solution.
EXAMPLE 4 A concentration was prepared by mixing together the following:
Weight percent Disodium dodecyldiphenyl oxide disulfonate 41.35 o-Phenylphenol 11.3 Water 47.35
The resulting composition was a clear solution.
Two parts by weight of the above composition was dis persed in parts by weight of water to produce a solution of tenfold dilution. The resulting solution was clear and homogeneous with no precipitation of the ophenylphenol.
EXAMPLE A built detergent-disinfectant concentrate having the 5 following composition was prepared:
Weight percent Disodium dodecyldiphenyl oxide disulfonate Dowicide 32 1 5 Tetrapotassium pyrophosphate 10 10 Water 75 Mixture of 4- and 6-ch1oro-2-pheny1-phenol, product of The Dow Chemical Company.
The above composition was a clear, stable, liquid com position and formed clear and stable solutions on dilution with water.
The above composition was diluted in tap water and the phenol coefficient determined by the official AOAC method as set forth in Ofiicial Methods of Analysis of the Association of Ofiicial Agricultural Chemists, published by the Association of Ofiicial Agricultural Chemists, Eighth Edition, 1955, pp. 87-91.
The phenol coefficients were found to be as follows: Organism: Phenol coefficient Staphylococcus aureus 4.7 Salmonella typhosa- 7.5
EXAMPLE 6 I The following detergent-disinfectant compositions were prepared ,with addition of water to complete the composition:
Percent by weight Composition A: I n in water o-Phenylphenol .L 5 Disodium dodecyldiphenyl oxide disulfonate 25 Composition B:
o-Phenylphenol 5 Disodium dodecyldiphenyl oxide disulfonate l5 Composition C: 40 o-Phenylphenol 5 Disodium dodecyldiphenyl oxide disulfonate 25 Sodium hydroxide 1 Composition D:
o-Phenylphenol S Disodium dodecyldiphenyl oxide disulfonate 5 Sodium hydr 1 Amount sufficient to form a salt with 75 percent of the o-phenylphenol.
Composition E: o-Phenylphenol 5 Disodium dodecyldipheny-l oxide disulfonate 10 Sodium hydroxide 2 Amount sufficient to form a salt with 50 percent of the o-phenylphenol.
The above compositions were all clear, homogeneous solutions. These solutions were stable on cooling to 0 C. with no precipitation of the o-phenylphenol.
EXAMPLE 7 Various built detergent-disinfectant compositions were prepared and the compositions examined for clarity and stability against precipitation of solids or separation of a second phase on cooling to freezing temperatures.
Percent by Weight in Water Composition Tetra- Appearance Sulfonate Dowicide potassium 32 pyrophosphate 1 3 3 3 Clear, stable.
2 a 3 6 Do.
.a 3 3 9 Do.
1 Sodium salt of disulf onated dodecyldiphenyl oxide.
EXAMPLE 8 Various built detergent-disinfectant compositions in which part of the phenolic germicide was present as its sodium salt were prepared and the compositions examined for clarity and stability against precipitation of solids or separation of a second phase.
Percent by Weight in Water Composition Tetrafi Sulfonate 1 Dowicide potassium 1 Normal 32 pyro- NaOH phosphate 1 Sodium salt of disulfonated dodecyldlphenyl oxide.
The above compositions were clear solutions and remained clear on being subjected to freezing temperatures.
EXAMPLE 9 A built detergent-disinfectant concentrate having, the following composition was prepared:
Weight percent Disodium dodecyldiphenyl oxide disulfonate 6 Dowicide 3 3 Tetrapotassiunr pyrophosphate 6 Water 8.5
The above composition was a clear, stable, liquid composition which further formed clear, stable solutions on dilutions with water.
The above composition was diluted with water and the phenol coefiicient determined by the oificial AOAC method. The phenol coefiicients were found to be as follows:
Organism: Phenol coeflicient Staphylococcus aureus 3.0 Salmonella typhosa 4.5
EXAMPLE 10 Various modified built detergent-disinfectant compositions were prepared wherein the modifying additament was an organic solvent and the phenol coefficient determined. All compositions were homogeneous and stable.
Percent by Weight in Water Phenol Oompo Coefllcient sition Tetra- Against Sulfonate 1 Dowicide potassium Sol- Staphylococcus 32 pyrovent aureus phosphate 1 Sodium salt of disulfonated dodecyldiphenyl oxide. A=17 .6 percent dipropylene glycol monomethyl ether. B=15.5 percent isopropyl alcohol.
EXAMPLE 11 The following detergent-disinfectant compositions are prepared by intimately mixing together the components.
Percent by weight in water Formulation A:
2-chloro-4-phenylphenol, sodium salt The above formulations are clear solutions which are stable on freezing and give clear solutions on addition to water.
1. A liquid concentrate detergent-disinfectant composition comprising an aqueous solution of a phenylphenol having the formula wherein X is selected from the group consisting of hydrogen and chloro and its water-soluble salts, said solution containing at least-1 percent by weight of said phenylphenol maintained in solution by an anionic dispersing a nt Qt he enera formu a wherein R is an alkyl radical containing from 9 to 15 carbon atoms, inclusive, and M is selected from a group consisting of alkali metal and ammonium.
2. A liquid detergent-disinfectant concentrate composition comprising 1) from 1 to 12 percent by weight of a phenyl substituted phenol having the formula wherein X' is selected from the group consistingof hydrogen and chloro and its water-soluble salts, and (2) an anionic dispersing agentof the general formula wherein R is an alkyl radical containing from 9 to 15 carbon atoms, inclusive, and M is selected from the group consisting of alkali metal and ammonium, said anionic dispersing agent being present in an amount of from 1 to 20 parts by weight for each part by weight of the phenyl substituted phenol.
3. A built liquid detergent disinfectant composition comprising an aqueous solution of (1) from 1 to 12 percent by weight of a phenyl-substituted phenol having the formula he e n X s se ed r m e gr p nsis in at h drogen and ch loro, and its water-soluble salts, and (2) an anionic dispersing agent of the general formula wherein R is an alkyl radical containing from 9 to 15 carbon atoms, inclusive, and M is selected from the group consisting o alkal meta and am on um said anionic dispersing agent being present in amount of from 1 to 20 parts by weight for each part by weight of the phenyl-substituted phenol, and (3) an alkaline builder.
References Cited in the file of this patent UNITED STATES PATENTS Monson Sept. 30, 1958 OTHER REFERENCES Reddish: Antiseptics, Disinfectants, Fungicides and Sterilization, 2nd Ed., 1957, pp. 526, 527, 532, 534.
Schwartz. Pery: Surface Active Agents (1949), p. 232.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2854447 *||Jun 4, 1953||Sep 30, 1958||Petrolite Corp||Process for preparing oxyalkylated derivatives|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US3067094 *||Feb 1, 1961||Dec 4, 1962||Cohen George||Composition for preserving feathers|
|US3250675 *||Jan 22, 1963||May 10, 1966||Bayer Ag||Soil treating or seed dressing agents for combatting phytopathogenic fungi|
|US3717590 *||Dec 17, 1970||Feb 20, 1973||Fetty R||Liquid water-soluble detergent compositions|
|US3933671 *||Feb 27, 1974||Jan 20, 1976||The Procter & Gamble Company||Germicidal cleaning composition and method|
|US4097395 *||Jan 17, 1977||Jun 27, 1978||Chempro Corporation||Mold and mildew removal composition and method of manufacture|
|US4124520 *||Jun 20, 1977||Nov 7, 1978||United States Borax & Chemical Corp.||Anti-microbial bathroom cleaning compositions containing o-benzyl-4-chlorophenol|
|US4627936 *||Oct 5, 1984||Dec 9, 1986||Gould Paper Corp.||Towel premoistened with antistatic solution for cleaning cathode-ray tubes and the like|
|US8008036||Sep 25, 2008||Aug 30, 2011||Curemark, Llc||Method for identifying autistic individuals amenable to digestive enzyme therapy|
|US8012710||Jun 19, 2009||Sep 6, 2011||Curemark, Llc||Methods of treating and diagnosing Parkinsons disease and related dysautonomic disorders|
|US8012930||Sep 6, 2011||Curemark, Llc||Methods of treating pervasive development disorders|
|US8030002||Oct 4, 2011||Curemark Llc||Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions|
|US8084025||Dec 27, 2011||Curemark Llc||Method for the treatment of the symptoms of drug and alcohol addiction|
|US8105584||Sep 8, 2008||Jan 31, 2012||Curemark Llc||Method for treating pervasive development disorders|
|US8163278||Oct 8, 2003||Apr 24, 2012||Curemark Llc||Methods for treating pervasive development disorders|
|US8211661||Jun 19, 2009||Jul 3, 2012||Curemark, Llc||Method for identifying individuals having a pervasive development disorder amenable to digestive enzyme therapy|
|US8318158||Nov 27, 2012||Curemark, Llc||Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same|
|US8486390||Jul 31, 2012||Jul 16, 2013||Curemark Llc||Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same|
|US8580522||Aug 12, 2011||Nov 12, 2013||Curemark, Llc||Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions|
|US8613918||May 25, 2012||Dec 24, 2013||Curemark Llc||Method for treating pervasive development disorders|
|US8658163||Mar 13, 2008||Feb 25, 2014||Curemark Llc||Compositions and use thereof for treating symptoms of preeclampsia|
|US8673877||Aug 8, 2011||Mar 18, 2014||Curemark, Llc||Use of lactulose in the treatment of autism|
|US8778335||Mar 11, 2008||Jul 15, 2014||Curemark, Llc||Methods of treating and diagnosing Parkinson's disease and related dysautonomic disorders|
|US8815233||Apr 16, 2012||Aug 26, 2014||Curemark Llc||Method for treating pervasive development disorders|
|US8921054||Sep 26, 2013||Dec 30, 2014||Curemark, Llc||Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions|
|US8980252||Apr 20, 2012||Mar 17, 2015||Curemark Llc||Methods of treatment of schizophrenia|
|US9017665||Jun 25, 2013||Apr 28, 2015||Curemark, Llc||Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same|
|US9023344||Sep 26, 2013||May 5, 2015||Curemark, Llc||Method of treating toxemia|
|US9056050||Apr 13, 2009||Jun 16, 2015||Curemark Llc||Enzyme delivery systems and methods of preparation and use|
|US9061033||Jan 9, 2013||Jun 23, 2015||Curemark Llc||Methods and compositions for the treatment of symptoms of prion diseases|
|US9084784||Jan 6, 2010||Jul 21, 2015||Curelon Llc||Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces|
|US9107419||Jan 6, 2010||Aug 18, 2015||Curelon Llc||Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces|
|US9233146||Sep 23, 2014||Jan 12, 2016||Curemark, Llc||Method of treating and diagnosing Parkinson's disease and related dysautonomic disorders|
|US9241907||Jul 28, 2011||Jan 26, 2016||Curemark, Llc||Enzyme delivery systems and methods of preparation and use|
|US9320780||Jun 26, 2009||Apr 26, 2016||Curemark Llc||Methods and compositions for the treatment of symptoms of Williams Syndrome|
|US9345721||Nov 22, 2013||May 24, 2016||Curemark, Llc||Use of lactulose in the treatment of autism|
|US9377459||Oct 30, 2014||Jun 28, 2016||Curemark Llc|
|US9408895||Mar 6, 2015||Aug 9, 2016||Curemark, Llc||Method of treating pregnancy-induced hypertension|
|US9415014||Jul 28, 2011||Aug 16, 2016||Curemark, Llc||Enzyme delivery systems and methods of preparation and use|
|US20020081628 *||Nov 16, 2001||Jun 27, 2002||Fallon Joan M.|
|US20040071683 *||Oct 8, 2003||Apr 15, 2004||Fallon Joan M.||Methods for treating pervasive development disorders|
|US20070155835 *||Jan 31, 2007||Jul 5, 2007||Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa)||Use of ortho-phenylphenol and/or derivatives thereof for inhibiting the asexual reproduction of fungi|
|US20080161265 *||Mar 17, 2008||Jul 3, 2008||Fallon Joan M||Use of lactulose in the treatment of autism|
|US20080219966 *||Mar 11, 2008||Sep 11, 2008||Fallon Joan M||Methods of treating pervasive development disorders|
|US20090197289 *||Sep 25, 2008||Aug 6, 2009||Fallon Joan M||Method for confirming a diagnosis of autism|
|US20090263372 *||Oct 22, 2009||Fallon Joan M|
|US20090285790 *||Jun 19, 2009||Nov 19, 2009||Fallon Joan M||Methods of treating and diagnosing parkinsons disease and related dysautonomic disorders|
|US20090286270 *||Jun 19, 2009||Nov 19, 2009||Fallon Joan M||Method for treating pervasive development disorders|
|USRE28778 *||Apr 2, 1975||Apr 20, 1976||West Laboratories, Inc.||Phenolic synthetic detergent-disinfectant|
|WO2006015725A2||Jul 28, 2005||Feb 16, 2006||Henkel Kommanditgesellschaft Auf Aktien||Use of ortho-phenylphenol and/or derivatives thereof for inhibiting the asexual reproduction of fungi|
|WO2006015725A3 *||Jul 28, 2005||Apr 27, 2006||Henkel Kgaa||Use of ortho-phenylphenol and/or derivatives thereof for inhibiting the asexual reproduction of fungi|
|WO2010080830A1 *||Jan 6, 2010||Jul 15, 2010||Curemark Llc||Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces|
|U.S. Classification||510/386, 510/505, 510/432, 510/426, 514/736, 510/497|
|International Classification||C11D3/48, C11D17/00|